These Analysts Revise Price Targets On Signify Health Following Acquisition News

These Analysts Revise Price Targets On Signify Health Following Acquisition News

CVS Health Corp CVS agreed to acquire Signify Health Inc SGFY for $30.50 per share in cash, representing a total transaction value of approximately $8 billion.

Signify Health shares gained 0.2% to $28.83 on Tuesday.

Several analysts made changes to their price targets on Signify Health today.

  • Baird boosted the price target on the stock from $28 to $30.5. Baird analyst Vikram Kesavabhotla downgraded the stock from Outperform to Neutral.
  • RBC Capital increased price target on the stock from $20 to $30.5. RBC Capital analyst Sean Dodge maintained Signify Health with a Sector Perform.
  • JP Morgan, however, lowered the price target on the stock from $32 to $30.5. JP Morgan analyst Anne Samuel downgraded the stock from Overweight to Neutral.
  • Piper Sandler also cut the price target on the stock from $34 to $30.5. Piper Sandler analyst Jessica Tassan downgraded the stock from Overweight to Neutral.
Posted In: PT ChangesM&ANewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading Ideas